Sildenafil Oral Disintegrating Tablets (ODT) (Quantity: 1)
Sildenafil is a popular and well-known treatment for erectile dysfunction (ED).
Oral Disintegrating Tablets (ODTs) Quantity: 1
Sildenafil is a popular and well-known treatment for erectile dysfunction (ED). Often known by its brand name Viagra, Sildenafil directs more blood flow to the penis by relaxing the muscles and expanding blood vessels. It’s a vasodilator and PDE-5 inhibitor.
Oral Disintegrating Tablets (ODTs)
This type of tablet disintegrates on the tongue within 60 seconds. It’s designed to enter the blood through the salivary glands rather than the digestive tract. This leads to faster onset of action and better absorption.
Other benefits of ODTs include:
—Can be taken without water
—Dissolve faster than troches
—Less possibility of an upset stomach, which is sometimes a symptom of capsules
—Able to be divided into smaller doses
| Pharmacy | N/A |
|---|---|
| Instructions | There are certain conditions under which sildenafil citrate should be administered with caution or outright avoided. Some of these conditions are: Hypersensitivity: Sildenafil is absolutely contraindicated in individuals who have a demonstrated hypersensitivity to the drug or any of its components. Nitrate therapy: Individuals who are not nitrate therapy should not be administered sildenafil citrate. Nitrates are potent vasodilators typically used in the management of cardiac conditions such as angina pectoris. Since sildenafil also a vasodilatory effect through its actions on cGMP, it can potentiate the effects of nitrates when used concurrently which may result in severe hypotension, syncope, and myocardial infarction. Hepatic disease: Since sildenafil is metabolized by hepatic isozymes, hepatic diseases may lead to increased plasma levels of sildenafil and a prolongation of its effects. Care should be exercised when administering sildenafil to individuals with hepatic disease. Renal disease: Similar to hepatic diseases, renal diseases may prolong the effects of sildenafil citrate due to increased plasma levels as a result of diminished renal excretion. Caution should also be exercised when administering sildenafil to individuals with renal diseases. Visual abnormalities: There have been some instances of vision loss in individuals taking sildenafil citrate. The loss of vision is due to a reduction in blood flow to the optic nerve, a condition known as non-arteritic anterior ischemic optic neuropathy (NAION). Individuals with pre-existing visual disturbances may be administered sildenafil only when the benefits clearly outweigh the risks. Cardiovascular disorders: Caution should be exercised when administering sildenafil to individuals with known cardiac disorders such as arrhythmias, aortic stenosis, heart failure, and myocardial infarction, among others. |